Resolution rates in clinical trials for microbiota restoration for recurrent infection: an updated systematic review and meta-analysis by Raseen Tariq, Darrell S. Pardi, Sahil Khanna

Get full text

Publication ethics and misconducts by Anurag Sachan, Sahil Khanna, Vishal Sharma

Get full text

The role of the gut microbiome in colonization resistance and recurrent infection by Anna Maria Seekatz, Nasia Safdar, Sahil Khanna

Get full text

Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication. by Chad Artman, Kyle D Brumfield, Sahil Khanna, Julius Goepp

Get full text

Durability and outcomes of fecal microbiota transplantation for recurrent infection in patients with moderate to severe inflammatory bowel disease by Raseen Tariq, Edward V Loftus, Darrell Pardi, Sahil Khanna

Get full text

Integrating Clinical Guidelines With ChatGPT-4 Enhances Its’ Skills by Raseen Tariq, MBBS, Elida Voth, MD, Sahil Khanna, MBBS, MS

Get full text

Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection by Erik R. Dubberke, Robert Orenstein, Sahil Khanna, Beth Guthmueller, Christine Lee

Get full text

Effect of peripartum infection on pregnancy and neonatal outcomes: an observational study by Srishti Saha, Ryan Pardi, Regan N. Theiler, Darrell S. Pardi, Sahil Khanna

Get full text

The natural history of histological changes in microscopic colitis by Kanika Sehgal, June Tome, Amrit K. Kamboj, Ross A. Dierkhising, Darrell S. Pardi, Sahil Khanna

Get full text

Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis by Arup Choudhury, Raseen Tariq, Anuraag Jena, Elissa Kinzelman Vesely, Siddharth Singh, Sahil Khanna, Vishal Sharma

Get full text

Safety of fecal microbiota, live-jslm (REBYOTA) in individuals with recurrent infection: data from five prospective clinical trials by Christine Lee, Thomas Louie, Lindy Bancke, Beth Guthmueller, Adam Harvey, Paul Feuerstadt, Sahil Khanna, Robert Orenstein, Erik R. Dubberke

Get full text

Body mass index changes after fecal microbiota transplantation for recurrent infection by Kanika Sehgal, Parul Berry, Janice Cho, George Saffouri, Ross A. Dierkhising, Eric Battaglioli, Purna C. Kashyap, Darrell Pardi, Sahil Khanna

Get full text

Lipoprotein Levels in Early Adulthood and NAFLD in Midlife: The Coronary Artery Risk Development in Young Adults (CARDIA) Study by Sahil Khanna, John T. Wilkins, Hongyan Ning, Norrina B. Allen, Cora E. Lewis, J. Jeffrey Carr, Donald Lloyd-Jones, Lisa B. VanWagner

Get full text

Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infecti... by Paul Feuerstadt, Jessica R. Allegretti, Erik R. Dubberke, Amy Guo, Adam Harvey, Min Yang, Viviana Garcia-Horton, Mirko Fillbrunn, Glenn Tillotson, Lindy L. Bancke, Kerry LaPlante, Kevin W. Garey, Sahil Khanna

Get full text

Safety, feasibility, and impact on the gut microbiome of kefir administration in critically ill adults by Vinod K. Gupta, Sanu Rajendraprasad, Mahmut Ozkan, Dhanya Ramachandran, Sumera Ahmad, Johan S. Bakken, Krzysztof Laudanski, Ognjen Gajic, Brent Bauer, Simon Zec, David W. Freeman, Sahil Khanna, Aditya Shah, Joseph H. Skalski, Jaeyun Sung, Lioudmila V. Karnatovskaia

Get full text

SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI) by Sahil Khanna, Matthew Sims, Thomas J. Louie, Monika Fischer, Kerry LaPlante, Jessica Allegretti, Brooke R. Hasson, Allyson T. Fonte, Christopher McChalicher, David S. Ege, Jessica A. Bryant, Timothy J. Straub, Christopher B. Ford, Matthew R. Henn, Elaine E. L. Wang, Lisa von Moltke, Mark H. Wilcox

Get full text

2092 A multicenter study of fecal microbiota transplantation for Clostridium difficile infection in children by Maribeth R. Nicholson, Erin Alexander, Mark Bartlett, Penny Becker, Zev Davidovics, Elizabeth E. Knackstedt, Michael Docktor, Michael Dole, Grace Felix, Jonathan Gisser, Suchitra Hourigan, Kyle Jensen, Jess Kaplan, Judith Kelsen, Melissa Kennedy, Sahil Khanna, McKenzie Leier, Jeffery Lewis, Ashley Lodarek, Sonia Michail, Paul Mitchell, Maria Oliva‐Hemker, Tiffany Patton, Karen Queliza, Namita Singh, Aliza Solomon, David Suskind, Steven Werlin, Richard Kellermayer, Stacy Kahn

Get full text

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators

Get full text

Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI by Colleen S. Kraft, Matthew Sims, Michael Silverman, Thomas J. Louie, Paul Feuerstadt, Edward S. Huang, Sahil Khanna, Charles S. Berenson, Elaine E. L. Wang, Stuart H. Cohen, Louis Korman, Christine Lee, Colleen R. Kelly, Alberto Odio, Paul P. Cook, Bret Lashner, Mayur Ramesh, Princy Kumar, Ananya De, Asli Memisoglu, David A. Lombardi, Brooke R. Hasson, Barbara H. McGovern, Lisa von Moltke, Darrell S. Pardi, on behalf of the ECOSPOR III and ECOSPOR IV investigators

Get full text